Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: Materials and end-product formulations

Journal of Drug Delivery Science and Technology

Volumn 21, Issue 1, 2011, Pages 43-54

  Souto, E B ^a,b   Doktorovova, S ^b   Boonme, P ^c  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Hydrogels; Lipid nanoparticles; Lipids; Microemulsions; Oils; Phospholipids; Triglycerides; Waxes

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CARBOMER; CELECOXIB; CETOSTEARYLIC ALCOHOL; CHITOSAN; DEPOPUR; DIOLEOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DOXORUBICIN; DYNASAN 112; DYNASAN 118; ECONAZOLE; EXCIPIENT; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; HEXADECANOL; HYDROXYETHYLCELLULOSE; INWITOR 900; LIPID; MICONAZOLE; MYRISTIC ACID ISOPROPYL ESTER; NANOCARRIER; NANOPARTICLE; OCTADECANOL; OLEYL ALCOHOL; POLOXAMER; POLYSORBATE 80; STEARIC ACID; TRILAURIN; TRIMYRISTIN; TRIPALMITIN; TRISTEARIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHAN;

COLLOID; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG STABILITY; HYDROGEL; MICROEMULSION; NONHUMAN; REVIEW; SKIN PENETRATION; SKIN PERMEABILITY; SKIN WATER LOSS; VISCOSITY;

EID: 79952222504     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(11)50005-X     Document Type: Review

References (165)

1. Reszko A.E., Berson D., Lupo M.P. - Cosmeceuticals: practical applications. - Dermatol. Clin., 27, 401-416, 2009.
2. Boonme P., Junyaprasert V.B., Suksawad N., Songkro S. - Microemulsions and nanoemulsions: novel vehicles for whitening cosmeceuticals. - J. Biomed. Nanotechnol., 5, 373-383, 2009.
3. Higaki K., Nakayama K., Suyama T., Amnuaikit C., Ogawara K., Kimura T. - Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. - Int. J. Pharm., 288, 227-233, 2005.
4. Schurer N.Y., Elias P.M. - The biochemistry and function of stratum corneum lipids. - Adv. Lipid Res., 24, 27-56, 1991.
5. Gallarate M., Trotta M., Battaglia L., Chirio D. - Preparation of solid lipid nanoparticles from w/o/w emulsions: preliminary studies on insulin encapsulation. - J. Microencapsul., 26, 394-402, 2009.
6. Martins S., Sarmento B., Souto E.B., Ferreira D.C. - Insulin-loaded alginate microspheres for oral delivery, Effect of polysaccharide reinforcement on physicochemical properties and release profile. - Carbohyd. Polym., 69, 725-731, 2007.
7. Basaran E., Demirel M., Sirmagul B., Yazan Y. - Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. - J. Microencapsul., 27, 37-47, 2010.
8. Shen J., Wang Y., Ping Q., Xiao Y., Huang X. - Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. - J. Control. Rel., 137, 217-223, 2009.
9. Gokce E.H., Sandri G., Egrilmez S., Bonferoni M.C., Guneri T., Caramella C. - Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes. - Curr. Eye Res., 34, 996-1003, 2009.
10. García-Fuentes M., Torres D., Alonso M.J. - Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. - Colloids Surf. B Biointerfaces, 27, 159-168, 2003.
11. Battaglia L., Trotta M., Gallarate M., Carlotti M.E., Zara G.P., Bargoni A. - Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: development and influence on insulin stability. - J. Microencapsul., 24, 672-684, 2007.
12. Souto E.B., Müller R.H. - Lipid nanoparticles, Effect on bioavailability and pharmacokinetics changes. - In: Handbook of Experimental Pharmacology, Novel Drug Delivery Approaches, Schäfer-Körting M. Ed., Springer Verlag Heidelberg, Berlin, Germany, 2009, pp. 115-142.
13. Kaur I.P., Bhandari R., Bhandari S., Kakkar V. - Potential of solid lipid nanoparticles in brain targeting. - J. Control. Rel., 127, 97-109, 2008.
14. Dong X., Mattingly C.A., Tseng M., Cho M., Adams V.R., Mumper R.J. - Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. - Eur. J. Pharm. Biopharm., 72, 9-17, 2009.
15. Estella-Hermoso de Mendoza A., Rayo M., Mollinedo F., Blanco-Prieto M.J. - Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: development and in vitro characterization. - Eur. J. Pharm. Biopharm., 68, 207-213, 2008.
16. Lu X., Howard M.D., Mazik M., Eldridge J., Rinehart J.J., Jay M., Leggas M. - Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization. - AAPS J., 10, 133-140, 2008.
17. Yuan H., Miao J., Du Y.Z., You J., Hu F.Q., Zeng S. - Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. - Int. J. Pharm., 348, 137-145, 2008.
18. Paliwal R., Rai S., Vaidya B., Khatri K., Goyal A K., Mishra N., Mehta A., Vyas S.P. - Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. - Nanomedicine, 5, 184-191, 2009.
19. Battaglia L., Gallarate M., Cavalli R., Trotta M. - Solid lipid nanoparticles produced through a coacervation method. - J. Microencapsul., 27, 78-85, 2010.
20. Teeranachaideekul V., Souto E.B., Muller R.H., Junyaprasert V.B. - Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels). - J. Microencapsul., 25, 111-120, 2008. (Pubitemid 351233917)
21. Souto E.B., Müller R.H., Gohla S. - A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acid. - J. Microencapsul., 22, 581-592, 2005.
22. Souto E.B., Anselmi C., Centini M., Müller R.H. - Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN). - Int. J. Pharm., 295, 261-268, 2005. (Pubitemid 40558808)
23. Teeranachaideekul V., Müller R.H., Junyaprasert V.B. - Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC), Effects of formulation parameters on physicochemical stability. - Int. J. Pharm., 340, 198-206, 2007.
24. Shah K.A., Date A.A., Joshi M.D., Patravale V.B. - Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. - Int. J. Pharm., 345, 163-171, 2007.
25. Joshi M., Patravale V. - Nanostructured lipid carrier (NLC) based gel of celecoxib. - Int. J. Pharm., 346, 124-132, 2008.
26. Joshi M., Patravale V. - Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib. - Drug Dev. Ind. Pharm., 32, 911-918, 2006.
27. Mandawgade S.D., Patravale V.B. - Development of SLNs from natural lipids: Application to topical delivery of tretinoin. - Int. J. Pharm., 363, 132-138, 2008.
28. Jensen L.B., Magnussson E., Gunnarsson L., Vermehren C., Nielsen H.M., Petersson K. - Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. - Int. J. Pharm., 390, 53-60, 2010.
29. Sharma P., Ganta S., Denny W.A., Garg S. - Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil. - Int. J. Pharm., 367, 187-194, 2009.
30. Bhalekar M., Pokharkar V., Madgulkar A., Patil N., Patil N. - Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. - AAPS PharmSciTech., 10, 289-296, 2009.
31. Attama A.A., Müller-Goymann C.C. - A critical study of novel physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oil. - Int. J. Pharm., 322, 67-78, 2006.
32. Kuntsche J., Bunjes H. - Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles. - Eur. J. Pharm. Biopharm., 67, 612-620, 2007.
33. Milak S., Medlicott N., Tucker I.G. - Solid lipid microparticles containing loratadine prepared using a Micromixer. - J. Microencapsul., 23, 823-831, 2006.
34. Souto E.B., Mehnert W., Muller R.H. - Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. - J. Microencapsul., 23, 417-433, 2006.
35. Müller R.H., Runge S.A., Ravelli V., Thünemann A.F., Mehnert W., Souto E.B. - Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation. - Eur. J. Pharm. Biopharm., 68, 535-544, 2008.
36. Subedi R.K., Kang K.W., Choi H.-K. - Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. - Eur. J. Pharm. Sci., 37, 508-513, 2009.
37. Li Y., Taulier N., Rauth A., Wu X. - Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN). - Pharm. Res., 23, 1877-1887, 2006.
38. Mehnert W., Mader K. - Solid lipid nanoparticles: Production, characterization and applications. - Adv. Drug Deliv. Rev., 47, 165-196, 2001.
39. Mader K. - Solid lipid nanoparticles as drug carriers. - In: Nanoparticulates as Drug Carriers., Torchilin V.P. Ed., Imperial College Press, London, UK, 2006, pp. 217-243.
40. Pouton C.W., Porter C.J. - Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. - Adv. Drug Deliv. Rev., 60, 625-637, 2008.
41. Radomska-Soukharev A. - Stability of lipid excipients in solid lipid nanoparticles. - Adv. Drug Deliv. Rev., 59, 411-418, 2007.
42. Radomska-Soukharev A., Muller R.H. - Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability. - Pharmazie, 61, 425-430, 2006. (Pubitemid 43724419)
43. Dong X., Mumper R.J. - The metabolism of fatty alcohols in lipid nanoparticles by alcohol dehydrogenase. - Drug Dev. Ind. Pharm., 32, 973-980, 2006.
44. Li J. - Quantitative analysis of cosmetics waxes by using supercritical fluid extraction (SFE)/supercritical fluid chromatography (SFC) and multivariate data analysis. - Chemometr. Intell. Lab., 45, 385-395, 1999.
45. Jannin V., Musakhanian J., Marchaud D. - Approaches for the development of solid and semi-solid lipid-based formulations. - Adv. Drug Deliv. Rev., 60, 734-746, 2008.
46. Pharmaceutical Excipients. - Sasol, 2008.
47. Johnson W. Jr., Cosmetic Ingredient Review Expert Panel. - Final report on the safety assessment of trilaurin, triarachidin, tribehenin, tricaprin, tricaprylin, trierucin, triheptanoin, triheptylun-decanoin, triisononanoin, triisopalmitin, triisostearin, trilinolein, trimyristin, trioctanoin, triolein. - Int. J. Tox., 20, Suppl. 4, 61-94, 2001.
48. http://www.cfsan.fda.gov/%7Edms/opa-appa.html
49. Olbrich C., Kayser O., Muller R.H. - Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN), Effect of surfactants, storage time and crystallinity. - Int. J. Pharm., 237, 119-128, 2002.
50. Sasol - Dynasan 114, 116, 118 microcrystalline triglycerides. - Product Info, 2007.
51. Siekmann B., Westesen K. - Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. - Colloids Surf. B Biointerfaces, 3, 159-175, 1994.
52. Bunjes H., Westesen K., Koch M.H.J. - Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. - Int. J. Pharm., 129, 159-173, 1996.
53. Bunjes H., Westesen K. - Influences of colloidal state on physical properties of solid fats. - In: Processes in Fats and Lipid Systems, Garti N. and Sato K. Eds., Marcel Dekker, Inc., New York, 2001, pp. 457-483.
54. Bunjes H., Koch M.H.J., Westesen K. - Effect of particle size on colloidal solid triglycerides. - Langmuir, 16, 5234-5241, 2000.
55. Higami M., Ueno S., Segawa T., Iwanami K., Sato K. - Simultaneous synchrotron radiation X-ray diffraction-DSC analysis of melting and crystallization behavior of trilauroylglycerol in nanoparticles of oil-in-water emulsion. - J. Am. Oil Chem. Soc., 80, 731-739, 2003.
56. Souto E.B., Müller R.H. - Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. - J. Microencapsul., 23, 377-388, 2006.
57. Souto E.B. - SLN and NLC for topical delivery of antifungals. - PhD thesis, Free University of Berlin, 2005.
58. Bhalekar M.R., Pokharkar V., Madgulkar A., Patil N. - Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. - AAPS PharmSciTech., 10, 289-296, 2009.
59. Niu M., Shi K., Sun Y., Wang J., Cui F. - Preparation of CyA-loaded solid lipid nanoparticles and application on ocular preparations. - J. Drug Del. Sci. Tech., 18, 293-297, 2008.
60. Gattefossé. - Pharmaceutical Product Catalogue (Topical Catalogue).
61. Souto E.B., Mehnert W., Müller R.H. - Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. - J. Microencapsul., 23, 417-433, 2006.
62. nd ed., Gunstone F., Harwood J.L. and Padley F.B. Eds., CRC Press, 1994, p. 665.
63. Veenstra G., Webb C., Sanderson H., Belanger S.E., Fisk P., Nielsen A., Kasai Y., Willing A., Dyer S., Penney D., Certa H., Stanton K., Sedlak R. - Human health risk assessment of long chain alcohols. - Ecotoxicol. Environ. Saf., 72, 1016-1030, 2009.
64. Souto E.B., Wissing S.A., Barbosa C.M., Muller R.H. - Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations. - J. Cosmet. Sci., 55, 463-471, 2004.
65. Zhang L., Qian Y., Long C., Chen Y. - Systematic procedures for formulation design of drug-loaded solid lipid microparticles: selection of carrier material and stabilizer. - Ind. Eng. Chem. Res., 47, 6091-6100, 2008.
66. Koziara J., Oh J., Akers W., Ferraris S., Mumper R. - Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. - Pharm. Res., 22, 1821-1828, 2005.
67. Ma P., Dong X.W., Swadley C.L., Gupte A., Leggas M., Ledebur H.C., Mumper R.J. - Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome pgp-mediated multiple drug resistance in leukemia. - J. Biomed. Nanotechnol., 5, 151-161, 2009.
68. Lockman P.R., Koziara J.M., Mumper R.J., Allen D.D. - Nanoparticle surface charges alter blood-brain barrier integrity and permeability. - J. Drug Target, 12, 635-641, 2004.
69. Jacob S.E., Chimento S., Castanedo-Tardan M.P. - Allergic contact dermatitis to propolis and carnauba wax from lip balm and chewable vitamins in a child. - Contact Dermatitis, 58, 242-243, 2008.
70. Buchwald R., Breed M.D., Greenberg A.R. - The thermal properties of beeswaxes: unexpected findings. - J. Exp. Biol., 211, 121-127, 2008.
71. Jenning V., Gohla S. - Comparison of wax and glyceride solid lipid nanoparticles (SLN). - Int. J. Pharm., 196, 219-222, 2000. (Pubitemid 30105747)
72. Attama A.A., Müller-Goymann C.C. - Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. - Colloids Surf. A Physicochem. Eng. Asp., 315, 189-195, 2008.
73. Attama A.A., Schicke B.C., Müller-Goymann C.C. - Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems. - Eur. J. Pharm. Biopharm., 64, 294-306, 2006.
74. Villalobos-Hernändez J.R., Müller-Goymann C.C. - Novel nanoparticulate carrier system based on carnauba wax and decyl oleate for the dispersion of inorganic sunscreens in aqueous media.- Eur. J. Pharm. Biopharm., 60, 113-122, 2005.
75. Villalobos-Hernändez J.R., Müller-Goymann C.C. - In vitro erythemal UV-A protection factors of inorganic sunscreens distributed in aqueous media using carnauba wax-decyl oleate nanoparticles. - Eur. J. Pharm. Biopharm., 65, 122-125, 2007.
76. Ruktanonchai U., Limpakdee S., Meejoo S., Sakulkhu U., Bunyapraphatsara N., Junyaprasert V., Puttipipatkhachorn S. - The effect of cetyl palmitate crystallinity on physical properties of gamma-oryzanol encapsulated in solid lipid nanoparticles. - Nanotechnology, 19, 10, 2008.
77. Teeranachaideekul V., Souto E.B., Junyaprasert V.B., Müller R.H. - Cetyl palmitate-based NLC for topical delivery of coenzyme Q10, Development, physicochemical characterization and in vitro release studies. - Eur. J. Pharm. Biopharm., 67, 141-148, 2007.
78. Saupe A., Gordon K.C., Rades T. - Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. - Int. J. Pharm., 314, 56-62, 2006.
79. Kumar V.V., Chandrasekar D., Ramakrishna S., Kishan V., Rao Y.M., Diwan P.V. - Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. - Int. J. Pharm., 335, 167-175, 2007.
80. Müller R.H., Rühl D., Runge S.A. - Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. - Int. J. Pharm., 144, 115-121, 1996.
81. Weyhers H., Ehlers S., Hahn H., Souto E.B., Muller R.H. - Solid lipid nanoparticles (SLN), Effects of lipid composition on in vitro degradation and in in vivo toxicity. - Pharmazie, 61, 539-544, 2006. (Pubitemid 43989132)
82. Fiume Z. - Final report on the safety assessment of lecithin and hydrogenated lecithin. - Int. J.Tox., 20, Suppl. 1, 21-45, 2001.
83. Fenske D.B., Cullis P.R. - Liposomal nanomedicines. - Expert Opin. Drug Deliv., 5, 25-44, 2008.
84. Torchilin V. - Antibody-modified liposomes for cancer chemotherapy. - Expert Opin. Drug Deliv., 5, 1003-1025, 2008.
85. Synthetic Glycerol-Based Lipids, ProductCatalogue.-AvantiPolarLipids, 2009.
86. Lecithins and Phospholipids. Product Catalogue. - Lipoid GmbH.
87. Bunjes H., Koch M.H.J. - Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. - J. Control. Rel., 107, 229-243, 2005.
88. Lv Q., Yu A., Xi Y, Li H., Song Z., Cui J., Cao F., Zhai G. - Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. - Int. J. Pharm., 372, 191-198, 2009.
89. Vivek K., Reddy H., Murthy R.S. - Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. - AAPS PharmSciTech, 8, E83, 2007.
90. Liu J., Gong T., Fu H., Wang C., Wang X., Chen Q., Zhang Q., He Q. and Zhang Z. - Solid lipid nanoparticles for pulmonary delivery of insulin. - Int. J. Pharm., 356, 333-344, 2008.
91. Liu J., Gong T., Wang C., Zhong Z., Zhang Z. - Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization. - Int. J. Pharm., 340, 153-162, 2007.
92. Allard E., Huynh N.T., Vessicres A., Pigeon P., Jaouen G., Benoit J.P., Passirani C. - Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model. - Int. J. Pharm., 379, 317-323, 2009.
93. Barras A., Mezzetti A., Richard A., Lazzaroni S., Roux S., Melnyk P., Betbeder D., Monfilliette-Dupont N. - Formulation and characterization of polyphenol-loaded lipid nanocapsules. - Int. J. Pharm., 379, 270-277, 2009.
94. Heurtault B., Saulnier P., Pech B., Proust J.-E., Benoit J.-P. - A novel phase inversion-based process for the preparation of lipid nanocarriers. - Pharm. Res., 19, 875-880, 2002.
95. Lacoeuille F., Garcion E., Benoit J.P., Lamprecht A. - Lipid nanocapsules for intracellular drug delivery of anticancer drugs. - J. Nanosci. Nanotechnol., 7, 4612-4617, 2007.
96. Morille M., Passirani C., Letrou-Bonneval E., Benoit J.P., Pitard B. - Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting. - Int. J. Pharm., 379, 293-300, 2009.
97. Babu Dhanikula A., Mohamed Khalid N., Lee S.D., Yeung R., Risovic V., Wasan K.M., Leroux J.-C. - Long circulating lipid nanocapsules for drug detoxification. - Biomaterials, 28, 1248-1257, 2007.
98. Senyigit T., Sonvico F., Barbieri S., Ozer O., Santi P., Colombo P. - Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. - J. Control. Rel., 142, 368-373, 2010.
99. Eskandar N.G., Simovic S., Prestidge C.A. - Mechanistic insight into the dermal delivery from nanoparticle-coated submicron o/w emulsions. - J. Pharm. Sci., 99, 890-904, 2010.
100. Kamiya S., Kurita T., Miyagishima A., Itai S., Arakawa M. - Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying. - Eur. J. Pharm. Biopharm., 74, 461-466, 2010.
101. Cui Z., Qiu F., Sloat B.R. - Lecithin-based cationic nanoparticles as a potential DNA delivery system. - Int. J. Pharm., 313, 206-213, 2006.
102. Attama A.A., Müller-Goymann C.C. - Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. - Int. J. Pharm., 334, 179-189, 2007.
103. Attama A.A., Reichl S., Müller-Goymann C.C. - Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. - Int. J. Pharm., 355, 307-313, 2008.
104. Attama A.A., Schicke B.C., Paepenmüller T., Müller-Goymann C.C. - Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization. - Eur. J. Pharm. Biopharm., 67, 48-57, 2007.
105. Shahani K., Jonnalagadda S.H., Handa H., Mao G., Panyam J. - Phospholipid nanoparticles: process optimization using factorial design and atomic force microscopy. - J. Biomed. Nanotech., 3, 394-400, 2007.
106. Oyewumi M.O., Mumper R.J. - Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy. - Bioconjug. Chem., 13, 1328-1335, 2002.
107. Shi K., Jiang Y., Zhang M., Wang Y., Cui F. - Tocopheryl succinate-based lipid nanospheres for paclitaxel delivery: preparation, characters, and in vitro release kinetics. - Drug Deliv., 17, 1, 1-10, 2010.
108. Hu F.Q., Wu M., Yuan H., Zhang H.H. - A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release. - Pharmazie, 59, 683-685, 2004. (Pubitemid 39281005)
109. Kim S., Jang D., Kim J., Park J., Lim J., Lee S., Lee K., Lim S., Kim C. - Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. - Pharmazie, 64, 510-514, 2009.
110. Schulman J.H., Montagne J.B.- Formation of microemulsions by amino alkyl alcohols. - Ann. NY Acad. Sci., 92, 366-371, 1961.
111. Boonme P. - Applications of microemulsions in cosmetics. - J. Cosmet. Dermatol., 6, 223-228, 2007.
112. Linn E.E., Pohland R.C., Byrd T.K. - Microemulsion for intradermal delivery of cetyl alcohol and octyl dimethyl PABA. - Drug Dev. Ind. Pharm., 16, 899-920, 1990.
113. Delgado-Charro M.B., Iglesias-Vilas G., Blanco-Mendez J., Lopez-Quintela M.A., Marty J., Guy R.H. - Delivery of a hydrophilic solute through the skin from novel microemulsion systems. - Eur. J. Pharm. Biopharm., 43, 37-42, 1997.
114. Bolzinger M.A., Carduner T.C., Poelman M.C. - Bicontinuous sucrose ester microemulsion: a new vehicle for topical delivery of niflumic acid. - Int. J. Pharm., 176, 39-45, 1998.
115. Changez M., Varshney M. - Aerosol-OT microemulsions as transdermal carriers of tetracaine hydrochloride. - Drug Dev. Ind. Pharm., 26, 507-512, 2000.
116. Baroli B., Lopez-Quintela M.A., Delgado-Charro M.B., Fadda A.M., Blanco-Mendez J. - Microemulsions for topical delivery of 8-methoxsalen. - J. Control. Rel., 69, 209-218, 2000.
117. Kreilgaard M., Pedersen E.J., Jaroszewski J.W. - NMR characterisation and transdermal drug delivery potential of microemulsion systems. - J. Control. Rel. 69, 421-433, 2000.
118. Rhee Y., Choi J., Park E., Chi S. - Transdermal delivery of ketoprofen using microemulsions. - Int. J. Pharm., 228, 161-170, 2001.
119. Paolino D., Ventura C.A., Nistico S., Puglisi G., Fresta M. - Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. - Int. J. Pharm., 244, 21-31, 2002.
120. Lee P.J., Langer R., Shastri V.P. - Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. - Pharm. Res., 20, 264-269, 2003.
121. Peltola S., Saarinen-Savolainen P., Kiesvaara J., Suhonen T.M., Urtti A. - Microemulsions for topical delivery of estradiol. - Int. J. Pharm., 254, 99-107, 2003.
122. Sintov A.C., Shapiro L. - New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. - J. Control. Rel., 95, 173-183, 2004.
123. Chen H., Chang X., Weng T., Zhao X., Gao H., Yang Y., Xu H., Yang X. - A study of microemulsion systems for transdermal delivery of triptolide. - J. Control. Rel., 98, 427-436, 2004.
124. Junyaprasert V.B., Boonsaner P., Leatwimonlak S., Boonme P. - Enhancement of the skin permeation of clindamycin phosphate by Aerosol OT/1-butanol microemulsions. - Drug Dev. Ind. Pharm., 33 (8), 874-880, 2007.
125. Müller R., Lucks J. - Arzneistoffträger aus festen Lipidteilchen - Feste Lipid Nanosphären (SLN). - European Patent 0605497, 1996.
126. Muller R.H., Gohla S., Mader K. - Solid lipid nanoparticles ( SLN) for controlled drug delivery - a review of the state of the art. - Eur. J. Pharm. Biopharm., 50, 161-177, 2000.
127. Gasco M. - Method for producing solid lipid microspheres having a narrow size distribution. - US Patent 5 250 236, 1993.
128. Souto E.B., Müller R.H. - Lipid nanoparticles (SLN and NLC) for drug delivery. - In: Nanoparticles for Pharmaceutical Applications, Domb A.J., Tabata Y., Ravi Kumar M.N.V., Farber S. Eds., American Scientific Publishers, Los Angeles, 2007, pp.103-122.
129. Bondi M.L., Craparo E.F. - Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art. - Expert Opin Drug Deliv, 7, 7-18, 2010.
130. Pardeike J., Hommoss A., Muller R.H.- Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. - Int. J. Pharm., 366, 170-184, 2009.
131. Joshi M.D., Müller R.H. - Lipid nanoparticles for parenteral delivery of actives. - Eur. J. Pharm. Biopharm., 71, 161-172, 2009.
132. Muchow M., Maincent P., Muller R.H. - Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. - Drug Dev. Ind. Pharm., 34, 1394-1405, 2008.
133. Korting H., Schafer-Korting M. - Carriers in the topical treatment of skin disease. - In: Handb. Exp. Pharmacol., Ed., 2010, pp. 435-468.
134. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H.C., Kramer K. D., Schäfer-Korting M. - Glucocorticoid entrapment into lipid carriers, Characterisation by parelectric spectroscopy and influence on dermal uptake. - J. Control. Rel. 97, 493-502, 2004.
135. Maia C.S., Mehnert W., Schäfer-Korting M. - Solid lipid nanoparticles as drug carriers for topical glucocorticoids. - Int. J. Pharm., 196, 165-167, 2000.
136. Stecova J., Mehnert W., Blaschke T., Kleuser B., Sivaramakrishnan R., Zouboulis C.C., Seltmann H., Korting H.C., Kramer K.D., Schafer-Korting M. - Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. - Pharm. Res., 24, 991-1000, 2007.
137. Braem C., Blaschke T., Panek-Minkin G., Herrmann W., Schlupp P., Paepenmuller T., Muller-Goyman C., Mehnert W., Bittl R., Schafer-Korting M., Kramer K.D. - Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. - J. Control. Rel., 119, 128-135, 2007.
138. Küchler S., Abdel-Mottaleb M., Lamprecht A., Radowski M.R., Haag R., Schafer-Korting M. - Influence of nanocarrier type and size on skin delivery of hydrophilic agents. - Int. J. Pharm., 377, 169-172, 2009.
139. Manso A.I., Doktorovova S., Santos D., Lopes C.M., Souto E.B. - Pre-formulation studies for NLC-based formulation for topical Fluticasone propionate delivery. - AAPS Annual Meeting, Los Angeles, AAPS Ed., p. 600.
140. Sanna V., Caria G., Mariani A. - Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of Econazole nitrate. - PowderTechnology, 201, 32-36 2010.
141. Sanna V., Mariani A., Caria G., Sechi M. - Synthesis and evaluation of different fatty acid esters formulated into Precirol reg; ATO-based lipid nanoparticles as vehicles for topical delivery. - Chem. Pharm. Bull., 57, 680-684, 2009.
142. Küchler S., Wolf N.B., Heilmann S., Weindl G., Helfmann J., Yahya M.M., Stein C., Schafer-Korting M. - 3D-Wound healing model: Influence of morphine and solid lipid nanoparticles. - J. Biotechnol., 148, 24-30, 2010.
143. Wolf N.B., Küchler S., Radowski M.R., Blaschke T., Kramer K.D., Weindl G., Kleuser B., Haag R., Schafer-Korting M. - Influences of opioids and nanoparticles on in vitro wound healing models. - Eur. J. Pharm. Biopharm., 73, 34-42, 2009.
144. Pathak P., Nagarsenker M. - Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. - AAPS PharmSciTech., 10, 985-992, 2009.
145. Lippacher A., Muller R.H., Mader K. - Liquid and semisolid SLN dispersions for topical application: rheological characterization. - Eur. J. Pharm. Biopharm., 58, 561-567, 2004.
146. Lippacher A., Muller R.H., Mader K. - Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. - Int. J. Pharm., 214, 9-12, 2001.
147. Souto E.B., Wissing S.A., Barbosa C.M., Müller R.H. - Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. - Eur. J. Pharm. Biopharm., 58, 83-90, 2004.
148. Jenning V., Schafer-Korting M., Gohla S. - Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. - J. Control. Rel., 66, 115-126, 2000.
149. Sanna V., Gavini E., Cossu M., Rassu G., Giunchedi P. - Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in vitro characterization, ex vivo and in vivo studies. - J. Pharm. Pharmacol., 59, 1057-1064, 2007. (Pubitemid 47265352)
150. Puglia C., Blasi P., Rizza L., Schoubben A., Bonina F., Rossi C., Ricci M. - Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. - Int. J. Pharm., 357, 295-304, 2008.
151. Ricci M., Puglia C., Bonina F., Di Giovanni C., Giovagnoli S., Rossi C. - Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. - J. Pharm. Sci., 94, 1149-1159, 2005.
152. Silva A.C., Santos D., Ferreira D.C., Souto E.B. - Minoxidilloaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. - Pharmazie, 64, 177-182, 2009.
153. Liu W., Hu M., Liu W., Xue C., Xu H., Yang X. - Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. - Int. J. Pharm., 364, 135-141, 2008.
154. Pople P., Singh K. - Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. - AAPS PharmSciTech., 7, E63-E69, 2006.
155. Casadei M.A., Cerreto F., Cesa S., Giannuzzo M., Feeney M., Marianecci C., Paolicelli P. - Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations. - Int. J. Pharm., 325, 140-146, 2006.
156. Paolicelli P., Cerreto F., Cesa S., Feeney M., Corrente F., Marianecci C., Casadei M.A. - Influence of the formulation components on the properties of the system SLN-dextran hydrogel for the modified release of drugs. - J. Microencapsul., 26, 355-364, 2009.
157. Valenta C., Schultz K. - Influence of carrageenan on the rheology and skin permeation of microemulsion formulations. - J. Control. Rel., 95, 257-265, 2004.
158. Chen H., Chang X., Du D., Li J., Xu H., Yang X. - Microemulsion-based hydrogel formulation of ibuprofen fortopical delivery. - Int. J. Pharm., 315, 52-58, 2006.
159. Chen H., Mou D., Du D., Chang X., Zhu D., Liu J., Xu H., Yang X. - Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration. - Int. J. Pharm., 341, 78-84, 2007.
160. Zhu W., Yu A., Wang W., Dong R., Wu J., Zhai G. - Formulation design of microemulsion for dermal delivery of penciclovir. - Int. J. Pharm., 360, 184-190, 2008.
161. Zhu W., Guo C., Yu A., Gao Y., Cao F., Zhai G. - Microemulsion-based hydrogel formulation of penciclovir for topical delivery. - Int. J. Pharm., 378, 152-158, 2009.
162. Feng G., Xiong Y., Wang H., Yang Y. - Gelation of microemulsions and release behavior of sodium salicylate from gelled microemulsions. - Eur. J. Pharm. Biopharm., 71, 297-302, 2009.
163. Kapoor Y., Chauhan A. - Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. - Int. J. Pharm., 361, 222-229, 2008.
164. Bachhav Y.G., Patravale V.B. - Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. - Int. J. Pharm., 365, 175-179, 2009.
165. Padula C., Nicoli S., Santi P. - Innovative formulations for the delivery of levothyroxine to the skin. - Int. J. Pharm., 372, 12-16, 2009.